Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Markets
Results
Mutual Funds
F&O
Reports
Stock screeners
Subscribe
Superstars
Portfolio
Watchlist
Alerts
Insider Trading & SAST
What's New
Trendlyne Baskets
Gainers/Losers
Market Breadth
Analyst Estimates
Results
Calendar
Tools
News by Trendlyne
Insider Trades
Global Indices
CEO Salary Dashboard
FAQs
S&P
20 Jan, 2026 4:30 PM (EST)
6817.51
-143.50
(
-2.06
%)
20
176
200
84
15
1
Dow
20 Jan, 2026 4:30 PM (EST)
48503.26
-877.07
(
-1.78
%)
1
10
11
7
1
US Tech Composite
20 Jan, 2026 4:30 PM (EST)
22971.26
-565.13
(
-2.40
%)
450
774
782
487
209
154
< -5%
-2 to -5%
0 to -2%
0 to 2%
2 to 5%
> 5%
Indices, Sector & Industry Dashboards
View Dashboard
Sector - Consumer Durables stocks today: Real-time Stock Market Dashboard
Sector - Consumer Durables: see top gainers, losers, volume screeners, and more
All Portfolio
All Watchlist
What's Happening
View all
20 Jan 2026
Newmont
Gold Surge
Newmont Corp. rises on Tuesday as gold hits a record above $4,700/oz due to geopolitical issues
U.S. Bancorp
Rising Revenue
US Bancorp's Q4 revenue rises 5.1% YoY on record consumer deposits and higher fee income
Fastenal
Estimates Miss
Fastenal's Q4 revenue narrowly misses estimates as tariffs lift prices for fasteners, nuts & bolts
D.R. Horton
Estimates Beat
D.R. Horton's Q1 revenue beats estimates by 3.8%, supported by discounts as buyers remain cautious
Applovin Corp (Class A)
Legal Concerns
AppLovin falls on Tuesday after reports allege primary shareholders used the firm to launder money
ImmunityBio Inc
Regulatory Tailwinds
ImmunityBio rises on Tuesday as FDA clears approval path for its bladder cancer drug, ANKTIVA
Progyny Inc
Analyst Upgrade
Citizens upgrades Progyny to a 'Market Outperform' rating; cites strong client retention rates
Novavax Inc
Licensing Agreement
Novavax enters a deal worth up to $530 mn with Pfizer to develop vaccines for infectious diseases
Forestar Grp Inc - Ordinary Shares New
Estimates Beat
Forestar's Q4 revenue jumps 9% YoY to $273 mn, beats Forecaster estimates by 3% on higher lot price
Fifth Third Bancorp
Estimates Beat
Fifth Third Bancorp's Q4 EPS jumps 22% YoY to $1, beats Forecaster estimates by 4% on AUM growth
3M
Estimates Beat
3M's Q4 EPS grows 9% YoY to $1.8, beats Forecaster estimates by 1.7% on strong execution
Brinker Intl Inc
Analyst Upgrade
UBS upgrades Brinker International to a 'Buy' rating; cites a strong sales momentum
Lululemon Athletica
Proxy Fight
Lululemon founder Chip Wilson seeks to remove PE firm Advent from its board in ongoing proxy fight
GSK PLC (ADR)
Acquisition
GSK to acquire RAPT Therapeutics for $2.2 billion, to boost its respiratory & allergy drug pipeline
Critical Metals Corp
Geopolitical Tailwinds
Critical Metals rises on Tuesday as Trump intensifies push to wrest Greenland from Denmark
19 Jan 2026
Garmin
Analyst Upgrade
Barclays upgrades Garmin to an 'Equalweight' rating; cites an attractive valuation
Honeywell
Analyst Upgrade
JP Morgan upgrades Honeywell International to 'Overweight'; raises the target price to $255
Range Resources Corp
Analyst Downgrade
BofA downgrades Range Resources to 'Neutral'; cites concerns over lower natural gas price forecast
GM
Regulatory Probe
NHTSA opens a probe to recall 59.7K General Motors vehicles over engine issues
KKR
Stake Purchase
KKR to increase its ~50% Altavair stake, citing resilience of aircraft assets across market cycles
Transdigm Group
Acquisition
Transdigm to acquire Jet Parts Engineering and Victor Sierra Aviation Holdings for around $2.2 bn
Paychex
Buyback
Paychex's board approves a share repurchase program worth $1 billion
Williams-Sonoma
Insider Trade
Laura Alber, President & CEO of Williams Sonoma, sells 35K shares worth $7.3 billion
AbbVie
Trial Setback
AbbVie and Genmab say that their blood cancer drug failed to meet endpoint in late stage trials
Micron Tech
Capacity Expansion
Micron to acquire Taiwanese chip-making site for $1.8 billion to meet demand for memory chips
View More
Top Gainers Stocks
View all
Top Losers Stocks
View all
New 52 Week High
View all
New 52 Week Low
View all
Relative Outperformance versus S&P 500 over 1 Week
View all
Relative Underperformance versus S&P 500 over 1 Week
View all
Volume Shockers
View all
High Volume, High Gain
View all
High Volume, Top Losers
View all
Positive Breakout Third Resistance (LTP > R3)
View all
Negative Breakdown Third Support (LTP < S3)
View all
Sectors Performance
Most Popular Stock Screeners